F32 F41.9 F41.1 F40
Conditions
Sponsors
Friedrich-Alexander Universität Erlangen-Nürnberg, Lehrstuhl für Klinische Psychologie und Psychotherapie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Minimum age 18; Signed consent form; Clinical diagnosis of depression determined by diagnostic interview
Exclusion criteria
Exclusion criteria: Acute suicidal tendency determined by initial diagnostic interview; unwilling to sign the consent form; psychotherapeutical treatment in the last 6 months or on waiting list for psychotherapy; self-report on present psychosis or dissociative symptoms; bipolar disorder in the past or present
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom severity of depression at time of post-measurement determined by: • Diagnostic interview (QIDS-C, Rush, Trivedi, Ibrahim, Carmody, Arnow, et al., 2003), time of measurement at Baseline (t1), Post (t2) and 6 months follow-up (t3) • Self-report (CES-D, Radloff, 1977; PHQ-9, Kroenke, Spitzer, Williams, 2001), CES-D on a weekly Basis (week 1 - 7), at t0, t1, t2, t3; PHQ at t1, t2, t3 t0 = Screening, before study inclusion t1 = Baseline t2 = Posttreatment (after completion of module 7 or after 8 weeks) t3 = 6-month follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| Diagnostic interview: • Disorder-specific symptom severity of anxiety (HAM-A, Hamilton, 1959; Shear, Vander, Bilt & Rucci, 2001) at t1, t2, t3 • Anxiety disorder or depressive disorder (Mini 6.0; Sheehan & Lecrubier, 2010) at t1, t2, t3 By self-report in questionnaires: • Disorder-specific symptom severity (e.g. depression, anxiety) (General Anxiety Disorder Measurement, GAD-7, Spitzer, Kroenke, Williams, et al., 2006), on a weekly basis (week 1 - week 7), at t0, t1, t2, t3 • Symptoms of depression (Patient Health Questionnaire, PHQ-9, Kroenke, Spitzer, Williams, 2001), at t1, t2, t3 • Sociodemographics (self developed) at t0 • Mental health (self developed) at t0 • Alcohol use (The Alcohol Use Disorder Identification Test, AUDIT-C, Babor et al., 2001) at t1, t2, t3 • Quality of life (EuroQol, EQ-5D, EuroQol Group, 1995) at t1, t2, t3 • Quality of life (Assessment Quality of Life, AQol-8D, Hawthorne, Richardson & Osborne, 1999) at t1, t2, t3 • Health economics (TIC-P, Beecham & Knapp, 2001) at t1, t3 • Training expectations (Credibility/Expectancy Questionnaire, CEQ, Devilly & Borkovec, 2000) at t1 • Negative effects of training (Inventory for the Assessment of Negative Effects of Psychotherapy, INEP, Ladwig, Rief & Nestoriuc, 2014) at t2 • Training satisfaction (Client Satisfaction Questionnaire, CSQ-8, Larsen, Attkisson, Hargreaves & Nguyen, 1979) at t2 • Risk factors questionnaire (self developed) at t1 • Sleep quality (Pittsburgh Sleep Quality Index, PSQI, Buysse et al., 1989) at t1, t2, t3 • Worrying (Penn State Worry Questionnaire Ultra Brief, PSWQ-3, Meyer, Miller, Metzger & Borkovec, 1990) at t1, t2, t3 • Self-assessment of emotional competencies (Subscales of assessment of Emotion Regulation Skills, SEK-27, Berking, 2008) at t1 • Incongruence (Incongruence questionnaire, INK-K, Grosse Holtforth, 2003) at t1, t2, t3 • Personality (Big Five Inventory, BFI-10, Rammstedt & John, 2007) at t1 • Behavioral activation (The Behavioral Activation for Depression Scal | — |
Countries
Germany, Switzerland
Contacts
Public ContactKiona Weisel
Lehrstuhl für Klinische Psychologie und Psychotherapie (KLiPs)Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Outcome results
None listed